Abstract
The antibacterial activity of Eucalyptus globulus leaf extract was determined for 56 isolates of Staphylococcus aureus, 25 isolates of Streptococcus pyogenes, 12 isolates of Streptococcus pneumoniae and seven isolates of Haemophilus influenzae obtained from 200 clinical specimens of patients with respiratory tract disorders. MIC50s for these species were 64, 32, 16 and 16 mg/L, respectively; MIC90s were 128, 64, 32 and 32 mg/L, respectively; and MBCs were 512, 128, 64 and 64 mg/L, respectively. These results suggest that further studies to clarify the possible therapeutic role of E. globulus leaf extract in the treatment of respiratory tract infection are warranted.
MeSH terms
-
Adolescent
-
Adult
-
Anti-Bacterial Agents / pharmacology*
-
Bacteria / drug effects*
-
Bacteria / isolation & purification
-
Eucalyptus / chemistry*
-
Female
-
Haemophilus influenzae / drug effects
-
Haemophilus influenzae / isolation & purification
-
Humans
-
Male
-
Microbial Sensitivity Tests
-
Middle Aged
-
Plant Extracts / pharmacology*
-
Respiratory Tract Infections / microbiology*
-
Staphylococcus aureus / drug effects
-
Staphylococcus aureus / isolation & purification
-
Streptococcus pneumoniae / drug effects
-
Streptococcus pneumoniae / isolation & purification
-
Streptococcus pyogenes / drug effects
-
Streptococcus pyogenes / isolation & purification
Substances
-
Anti-Bacterial Agents
-
Plant Extracts